Form 4 for IT Gartner
Accepted 2023-12-14 00:00:00 ET · period of report 2023-12-12 · accession 0001127602-23-029633 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-14 | 2023-12-12 | IT | Safian Craig | EVP, CFO | D - Sale to Iss | $460.62 | -4,037 | 73.3K | -5% | -$1.86M |
| D | 2023-12-14 | 2023-12-12 | IT | Safian Craig | EVP, CFO | F - Tax | $460.62 | -4,576 | 68.7K | -6% | -$2.11M |
| D | 2023-12-14 | 2023-12-12 | IT | Safian Craig | EVP, CFO | M - OptEx | $143.01 | +13.0K | 77.3K | +20% | +$1.86M |
| D | 2023-12-14 | 2023-12-13 | IT | Safian Craig | EVP, CFO | S - Sale+OE | $467.37 | -4,387 | 64.3K | -6% | -$2.05M |
| D | 2023-12-14 | 2023-12-12 | IT | Safian Craig | EVP, CFO | M - OptEx | $0.00 | -13.0K | 13.2K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-12 | D | D | 4,037 | $460.62 | 73,270 | D | — | — | (F2) Represents shares withheld that had an aggregate value, based on the market price on the date of exercise, substantially equal to the aggregate exercise price of the SARs. |
| 2 | Common | Common Stock | 2023-12-12 | F | D | 4,576 | $460.62 | 68,694 | D | — | — | (F3) Represents shares withheld for the payment of applicable income and payroll withholding taxes. |
| 3 | Common | Common Stock | 2023-12-12 | M | A | 13,000 | $143.01 | 77,307 | D | — | — | (F1) Represents shares acquired upon exercise of SARs. |
| 4 | Common | Common Stock | 2023-12-13 | S | D | 4,387 | $467.37 | 64,307 | D | — | — | |
| 5 | Derivative | Stock Appreciation Rights | 2023-12-12 | M | D | 13,000 | $0.00 | 13,196 | D | $143.01 · 2020-02-06 to 2026-02-06 | 13,000 Common Stock | (F4) These SARS are part of an award that became exercisable in four substantially equal annual installations, commencing on February 6, 2020, and are fully exercisable. |